Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9331 | 1165 | 33.1 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
131 | 3 | HEMATOLOGY//HAEMOPHILIA//TRANSFUSION | 66936 |
401 | 2 | TRANSFUSION//VOX SANGUINIS//BLOOD TRANSFUSION | 16732 |
9331 | 1 | PATHOGEN INACTIVATION//AMOTOSALEN//SOLVENT DETERGENT | 1165 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PATHOGEN INACTIVATION | authKW | 924195 | 6% | 49% | 72 |
2 | AMOTOSALEN | authKW | 740784 | 3% | 91% | 31 |
3 | SOLVENT DETERGENT | authKW | 547520 | 3% | 67% | 31 |
4 | PATHOGEN REDUCTION | authKW | 386135 | 3% | 39% | 38 |
5 | VIRUS INACTIVATION | authKW | 267177 | 4% | 24% | 42 |
6 | TRANSFUSION | journal | 259651 | 24% | 4% | 275 |
7 | PATHOGEN REDUCTION TECHNOLOGY | authKW | 221999 | 1% | 71% | 12 |
8 | FRESH FROZEN PLASMA | authKW | 221426 | 5% | 15% | 58 |
9 | SOLVENT DETERGENT TREATED PLASMA | authKW | 192990 | 1% | 82% | 9 |
10 | UNIVERSAL PLASMA | authKW | 183463 | 1% | 100% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 58421 | 68% | 0% | 788 |
2 | Biochemical Research Methods | 301 | 6% | 0% | 73 |
3 | Biotechnology & Applied Microbiology | 297 | 8% | 0% | 95 |
4 | Immunology | 187 | 8% | 0% | 92 |
5 | Biophysics | 127 | 5% | 0% | 57 |
6 | Pharmacology & Pharmacy | 60 | 7% | 0% | 81 |
7 | Virology | 52 | 2% | 0% | 25 |
8 | Medical Laboratory Technology | 37 | 1% | 0% | 14 |
9 | Peripheral Vascular Diseases | 25 | 2% | 0% | 25 |
10 | Anesthesiology | 6 | 1% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSFUS THER IES | 157254 | 1% | 100% | 6 |
2 | TECH OPERAT SERV | 109203 | 0% | 83% | 5 |
3 | GERMAN RED CROSS CH TERS | 104836 | 0% | 100% | 4 |
4 | PROGRAM BT NT FUS SCI TECHNOL | 83867 | 0% | 80% | 4 |
5 | OBRR BIOL EVALUAT | 78627 | 0% | 100% | 3 |
6 | SPRINGE | 62114 | 1% | 30% | 8 |
7 | RED CROSS SERV BADEN WURTTEMBERG HESSEN | 52418 | 0% | 100% | 2 |
8 | SHANGHAI BLOOD STUDENT TRAINING BASE | 52418 | 0% | 100% | 2 |
9 | COMPONENTS RD GRP | 34944 | 0% | 67% | 2 |
10 | RED CROSS BLOOD SERV NSTOB | 34944 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSFUSION | 259651 | 24% | 4% | 275 |
2 | VOX SANGUINIS | 171468 | 14% | 4% | 160 |
3 | TRANSFUSION AND APHERESIS SCIENCE | 65590 | 5% | 4% | 60 |
4 | BIOLOGICALS | 37252 | 4% | 3% | 44 |
5 | BLOOD TRANSFUSION | 28162 | 2% | 4% | 26 |
6 | TRANSFUSION MEDICINE AND HEMOTHERAPY | 24541 | 2% | 4% | 24 |
7 | TRANSFUSION MEDICINE REVIEWS | 13517 | 1% | 3% | 17 |
8 | TRANSFUSION CLINIQUE ET BIOLOGIQUE | 12479 | 2% | 2% | 23 |
9 | INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN | 12131 | 2% | 3% | 18 |
10 | BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT | 8731 | 0% | 11% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PATHOGEN INACTIVATION | 924195 | 6% | 49% | 72 | Search PATHOGEN+INACTIVATION | Search PATHOGEN+INACTIVATION |
2 | AMOTOSALEN | 740784 | 3% | 91% | 31 | Search AMOTOSALEN | Search AMOTOSALEN |
3 | SOLVENT DETERGENT | 547520 | 3% | 67% | 31 | Search SOLVENT+DETERGENT | Search SOLVENT+DETERGENT |
4 | PATHOGEN REDUCTION | 386135 | 3% | 39% | 38 | Search PATHOGEN+REDUCTION | Search PATHOGEN+REDUCTION |
5 | VIRUS INACTIVATION | 267177 | 4% | 24% | 42 | Search VIRUS+INACTIVATION | Search VIRUS+INACTIVATION |
6 | PATHOGEN REDUCTION TECHNOLOGY | 221999 | 1% | 71% | 12 | Search PATHOGEN+REDUCTION+TECHNOLOGY | Search PATHOGEN+REDUCTION+TECHNOLOGY |
7 | FRESH FROZEN PLASMA | 221426 | 5% | 15% | 58 | Search FRESH+FROZEN+PLASMA | Search FRESH+FROZEN+PLASMA |
8 | SOLVENT DETERGENT TREATED PLASMA | 192990 | 1% | 82% | 9 | Search SOLVENT+DETERGENT+TREATED+PLASMA | Search SOLVENT+DETERGENT+TREATED+PLASMA |
9 | UNIVERSAL PLASMA | 183463 | 1% | 100% | 7 | Search UNIVERSAL+PLASMA | Search UNIVERSAL+PLASMA |
10 | VIRAL INACTIVATION | 178634 | 2% | 31% | 22 | Search VIRAL+INACTIVATION | Search VIRAL+INACTIVATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PROWSE, CV , (2013) COMPONENT PATHOGEN INACTIVATION: A CRITICAL REVIEW.VOX SANGUINIS. VOL. 104. ISSUE 3. P. 183 -199 | 86 | 92% | 34 |
2 | CICCHETTI, A , BERRINO, A , CASINI, M , CODELLA, P , CORETTI, S , FACCO, G , FIORE, A , MARANO, G , MARCHETTI, M , MIDOLO, E , ET AL (2016) HEALTH TECHNOLOGY ASSESSMENT OF PATHOGEN REDUCTION TECHNOLOGIES APPLIED TO PLASMA FOR CLINICAL USE.BLOOD TRANSFUSION. VOL. 14. ISSUE 4. P. 287 -386 | 124 | 65% | 0 |
3 | SELTSAM, A , MULLER, TH , (2013) UPDATE ON THE USE OF PATHOGEN-REDUCED HUMAN PLASMA AND PLATELET CONCENTRATES.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 162. ISSUE 4. P. 442-454 | 71 | 80% | 25 |
4 | ROCK, G , (2011) A COMPARISON OF METHODS OF PATHOGEN INACTIVATION OF FFP.VOX SANGUINIS. VOL. 100. ISSUE 2. P. 169 -178 | 57 | 97% | 46 |
5 | LIUMBRUNO, GM , FRANCHINI, M , (2015) SOLVENT/DETERGENT PLASMA: PHARMACEUTICAL CHARACTERISTICS AND CLINICAL EXPERIENCE.JOURNAL OF THROMBOSIS AND THROMBOLYSIS. VOL. 39. ISSUE 1. P. 118 -128 | 57 | 81% | 6 |
6 | ABONNENC, M , SONEGO, G , CRETTAZ, D , ALIOTTA, A , PRUDENT, M , TISSOT, JD , LION, N , (2015) IN VITRO STUDY OF PLATELET FUNCTION CONFIRMS THE CONTRIBUTION OF THE ULTRAVIOLET B (UVB) RADIATION IN THE LESIONS OBSERVED IN RIBOFLAVIN/UVB-TREATED PLATELET CONCENTRATES.TRANSFUSION. VOL. 55. ISSUE 9. P. 2219 -2230 | 61 | 73% | 5 |
7 | RAMSEY, G , (2016) HEMOSTATIC EFFICACY OF PATHOGEN-INACTIVATED BLOOD COMPONENTS.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 42. ISSUE 2. P. 172 -182 | 48 | 84% | 1 |
8 | LOZANO, M , CID, J , (2013) PATHOGEN INACTIVATION: COMING OF AGE.CURRENT OPINION IN HEMATOLOGY. VOL. 20. ISSUE 6. P. 540-545 | 46 | 96% | 7 |
9 | SALUNKHE, V , VAN DER MEER, PF , DE KORTE, D , SEGHATCHIAN, J , GUTIERREZ, L , (2015) DEVELOPMENT OF BLOOD TRANSFUSION PRODUCT PATHOGEN REDUCTION TREATMENTS: A REVIEW OF METHODS, CURRENT APPLICATIONS AND DEMANDS.TRANSFUSION AND APHERESIS SCIENCE. VOL. 52. ISSUE 1. P. 19 -34 | 56 | 57% | 19 |
10 | PELLETIER, JPR , TRANSUE, S , SNYDER, EL , (2006) PATHOGEN INACTIVATION TECHNIQUES.BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. VOL. 19. ISSUE 1. P. 205-242 | 62 | 75% | 69 |
Classes with closest relation at Level 1 |